세계의 헬스케어 콜드체인 물류 시장 보고서 및 예측(2025-2033년)

The global healthcare cold chain logistics market size reached USD 18.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 23.2 Billion by 2033, exhibiting a growth rate (CAGR) of 2.8% during 2025-2033. The market is expanding due to rising global demand for biopharmaceuticals that are sensitive to temperature, growing vaccine industry, increasing clinical trials, and technological developments in refrigeration and monitoring systems that guarantee the safe distribution of pharmaceuticals.

Healthcare cold chain logistics refers to the specialized process of handling, transporting, and storing temperature-sensitive pharmaceuticals, vaccines, and biologics within a controlled temperature range. It is essential to maintain the efficacy and safety of these medical products throughout the supply chain, from manufacturing to distribution and ultimately to the end-user. Cold chain logistics involves the use of refrigerated or insulated containers, temperature-controlled warehouses, and advanced monitoring technologies to ensure that the products are kept within specified temperature ranges, protecting them from temperature excursions that could compromise their quality and effectiveness. As a result, this critical system plays a crucial role in safeguarding public health and ensuring the availability of reliable healthcare products across the globe.

The rising demand for temperature-sensitive pharmaceuticals, vaccines, and biologics that require a reliable and efficient cold chain logistics system to maintain product integrity and efficacy, will stimulate the growth of the market during the forecast period. Moreover, the escalating need for specialized temperature-controlled transportation and storage solutions due to the rapid expansion of the pharmaceutical and biotechnology industries is positively influencing the market growth. Apart from this, the increasing global health emergencies and vaccination programs, such as during the recent outbreak of the coronavirus (COVID-19) pandemic, has augmented the demand for seamless healthcare cold chain logistics to ensure the timely and safe distribution of life-saving medical products. Additionally, several stringent regulatory requirements and quality standards for healthcare products, including Good Distribution Practice (GDP) guidelines, has accelerated the adoption of specialized cold chain logistics services to comply with strict handling and monitoring protocols. Furthermore, the heightening focus on personalized medicine and biopharmaceuticals, which are often temperature-sensitive, is contributing to market growth.

Healthcare Cold Chain Logistics Market Trends/Drivers:

Growing demand for temperature-sensitive medical products

The market for healthcare cold chain logistics is fueled by an increase in the demand for temperature-sensitive pharmaceuticals, vaccines, and biologics worldwide. As the pharmaceutical and biotechnology industries continue to expand and innovate, there is a greater need for a reliable and efficient cold chain system to ensure the integrity and efficacy of these delicate medical products during transportation and storage. Maintaining a controlled temperature range throughout the supply chain is crucial to prevent temperature excursions that could compromise the quality and effectiveness of the products. This has led to a rise in investment in specialized healthcare cold chain logistics services and technologies to meet the growing demand and ensure the safe and reliable distribution of temperature-sensitive healthcare products.

Escalating global health emergencies and vaccination programs

The increasing prevalence of global health emergencies, such as pandemics and disease outbreaks, are contributing to the high demand for healthcare cold chain logistics. During these crises, the timely and efficient distribution of vaccines, pharmaceuticals, and medical supplies becomes crucial to curb the spread of diseases and protect public health. Effective vaccination programs rely on a robust healthcare cold chain logistics system to ensure that vaccines maintain their potency and efficacy from manufacturing to administration. The urgency to respond to health emergencies and implement large-scale vaccination campaigns highlights the critical importance of seamless cold chain logistics in the healthcare sector, underscoring its impact on global health outcomes.

Implementation of stringent regulatory compliance and quality standards

The healthcare industry operates under stringent regulatory requirements and quality standards to ensure patient safety and product efficacy. For temperature-sensitive medical products, adherence to Good Distribution Practice (GDP) guidelines is essential to guarantee that these products are stored, transported, and handled within the specified temperature ranges. Maintaining compliance with these regulations demands a high level of precision and accountability in healthcare cold chain logistics processes. The increase in emphasis on meeting regulatory compliance propels the demand for advanced healthcare cold chain logistics solutions that offer robust monitoring, data management, and validation capabilities to ensure quality and conformity throughout the supply chain.

Healthcare Cold Chain Logistics Industry Segmentation:

Breakup by Product:

Clinical Trial Materials

Vaccines

Biopharmaceuticals

Vaccines dominate the market

Vaccines play a central role as critical tools for preventing and controlling infectious diseases. They require stringent temperature control to maintain their potency and efficacy. The need for a robust cold chain is essential from the manufacturing stage to delivery to end-users, such as healthcare facilities and vaccination centers. Healthcare cold chain logistics ensures that vaccines are stored, transported, and handled within specified temperature ranges, safeguarding their integrity and effectiveness.

Moreover, the constant demand for vaccines, particularly during global health emergencies and vaccination programs, puts immense pressure on the healthcare cold chain logistics system to ensure timely and safe distribution. To meet this challenge, logistics providers are investing in specialized infrastructure, real-time monitoring technologies, and stringent quality control processes to maintain the cold chain's integrity and support the efficient delivery of vaccines, ultimately contributing to global health and disease prevention efforts, thus driving the growth of the vaccine segment.

Breakup by Segment:

Global Healthcare Cold Chain Logistics Market Share, By Segment (in %)

Transportation

Packaging

Instrumentation

20%

30%

50%

imarcgroup.com

Transportation 50

Packaging 30

Instrumentation 20

Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

Transportation

Packaging

Instrumentation

Packaging holds the largest share in the market

The safe and effective transportation of temperature-sensitive medical products heavily relies on specialized packaging solutions that maintain product integrity throughout the supply chain. Packaging ensures that pharmaceuticals, vaccines, and biologics are insulated from temperature excursions, protecting them from degradation and maintaining their efficacy. Advanced thermal protection materials, insulated containers, and temperature-monitoring devices are incorporated into healthcare cold chain packaging to provide a controlled environment and real-time visibility during transportation and storage.

Packaging innovations enable longer shelf life, enhanced stability, and reduced risk of spoilage for temperature-sensitive healthcare products, facilitating their safe distribution to end users. As the demand for temperature-sensitive medical products continues to rise, the market for healthcare cold chain logistics invests in cutting-edge packaging technologies and solutions to ensure the safe and reliable delivery of medical products, contributing significantly to patient safety and public health.

Breakup by Region:

North America

Europe

Asia Pacific

Rest of the world

Asia Pacific exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, and Rest of the World. According to the report, Asia Pacific was the largest regional market for healthcare cold chain logistics.

Asia Pacific held the biggest share in the market since the region is witnessing substantial population growth and increasing levels of urbanization, leading to a rise in demand for temperature-sensitive medical products, such as vaccines and biologics, to cater to the healthcare needs of its vast population.

Additionally, the prevalence of infectious diseases and the occurrence of health emergencies necessitate efficient cold chain logistics to ensure timely and safe distribution of medical supplies and vaccines. The region's thriving pharmaceutical and biotechnology industries also fuels the demand for specialized healthcare cold chain services to maintain the integrity and efficacy of medical products during transportation and storage. The increasing investment in upgrading the healthcare infrastructure across the Asia Pacific region, continuous technological advancements by regional industry players, and stringent regulatory compliance further supports the expansion of the market, driving its importance in the region's healthcare ecosystem.

Competitive Landscape:

The market is experiencing steady growth as various key players operating in the healthcare cold chain logistics industry have made significant contributions by providing specialized and reliable solutions to address the unique challenges of transporting temperature-sensitive medical products. Manufacturers are heavily investing in advanced technologies and infrastructure to ensure seamless temperature control throughout the supply chain. They are also offering temperature-monitored storage facilities, refrigerated transportation, and real-time monitoring systems to maintain product integrity and compliance with strict regulatory requirements. Vendors also play a crucial role in implementing innovative packaging solutions and thermal protection materials to safeguard the products from temperature excursions during transit. Additionally, they contribute to the market growth by providing specialized training and expertise to ensure the proper handling and distribution of temperature-sensitive healthcare products, ultimately supporting the healthcare industry in delivering safe and effective medical treatments to patients across the globe. We also expect the market to witness a rise in strategic collaborations and partnerships amongst key players, continual product innovations, and technological advancements to drive healthy competition within the domain.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Amerisource Bergen Corporation (World Courier)

Deutsche Post DHL Group

FedEx Corporation Services, Inc.

United Parcel Service of America, Inc.

Kuehne + Nagel International AG

Cavalier Logistics, Inc.

DB Schenker

Life ConEx

American Airlines Cargo

Continental Group

Marken Ltd.

Key Questions Answered in This Report

• 1. How big is the healthcare cold chain logistics market?
• 2. What is the expected growth rate of the global healthcare cold chain logistics market during 2025-2033?
• 3. What are the key factors driving the global healthcare cold chain logistics market?
• 4. What has been the impact of COVID-19 on the global healthcare cold chain logistics market?
• 5. What is the breakup of the global healthcare cold chain logistics market based on the product?
• 6. What is the breakup of the global healthcare cold chain logistics market based on the segment?
• 7. What are the key regions in the global healthcare cold chain logistics market?
• 8. Who are the key players/companies in the global healthcare cold chain logistics market?
• 9. How does cold chain logistics work?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 The Global Healthcare Cold Chain Products Market

• 4.1 Historical, Current and Future Market Trends
• 4.2 Market Segments
  • 4.2.1 Biopharmaceuticals
    • 4.2.1.1 Historical, Current and Future Market Trends
    • 4.2.1.2 Cold Chain Requirements for Biopharmaceuticals
    • 4.2.1.3 Cold Chain Opportunities for Biopharmaceuticals
  • 4.2.2 Vaccines
    • 4.2.2.1 Historical, Current and Future Market Trends
    • 4.2.2.2 Cold Chain Requirements for Vaccines
    • 4.2.2.3 Cold Chain Opportunities for Vaccines
  • 4.2.3 Clinical Trial Materials
    • 4.2.3.1 Historical, Current and Future Market Trends
    • 4.2.3.2 Cold Chain Requirements for Clinical Trial Materials
    • 4.2.3.3 Cold Chain Opportunities for Clinical Trial Materials

5 Healthcare Cold Chain Logistic Services Market

• 5.1 Current and Historical Market Trends
• 5.2 Impact of COVID-19
• 5.3 Market Breakup by Product
  • 5.3.1 Clinical Trial Materials
  • 5.3.2 Vaccines
  • 5.3.3 Biopharmaceuticals
• 5.4 Market Breakup by Segment
  • 5.4.1 Transportation
    • 5.4.1.1 Current and Historical Market Trends
    • 5.4.1.2 Market Breakup by Transportation Type
    • 5.4.1.3 Market Forecast
  • 5.4.2 Packaging
    • 5.4.2.1 Current and Historical Market Trends
    • 5.4.2.2 Market Breakup by Packaging Type
    • 5.4.2.3 Market Forecast
  • 5.4.3 Instrumentation
    • 5.4.3.1 Current and Historical Market Trends
    • 5.4.3.2 Market Breakup by Instrumentation Type
    • 5.4.3.3 Market Forecast
• 5.5 Market by Region
  • 5.5.1 North America
  • 5.5.2 Europe
  • 5.5.3 Asia Pacific
  • 5.5.4 Rest of the World

6 Value Chain Analysis

• 6.1 Drug Production Facility
• 6.2 Refrigerated Warehouse
• 6.3 Transport (Air/Sea/Road/Rail)
• 6.4 Distribution centres
• 6.5 Transport (Road)
• 6.6 End Users

7 Price Analysis

• 7.1 Price Indicators
• 7.2 Price Structure
• 7.3 Cost of Cold Chain Logistic Services Vs. Non-Cold Chain Logistic Services

8 SWOT Analysis

• 8.1 Overview
• 8.2 Strengths
• 8.3 Weaknesses
• 8.4 Opportunities
• 8.5 Threats

9 Porter's Five Forces Analysis

• 9.1 Overview
• 9.2 Bargaining Power of Buyers
• 9.3 Bargaining Power of Suppliers
• 9.4 Degree of Competition
• 9.5 Threat of New Entrants
• 9.6 Threat of Substitutes

10 Healthcare Cold Chain Logistics: How Does It Operate?

• 10.1 Cold Chain Packaging and Transportation Methods
  • 10.1.1 Dry Ice
  • 10.1.2 Liquid Nitrogen
  • 10.1.3 Gel Packs
• 10.2 Setting Up a Cold Chain
  • 10.2.1 Initial Considerations
  • 10.2.2 Choosing the Correct Model
  • 10.2.3 Regulatory/Custom Clearance
  • 10.2.4 Final Stages
  • 10.2.5 Quality Assurance

11 Competitive Landscape

• 11.1 Market Structure
• 11.2 Key Players
• 11.3 Profiles of Key Players
  • 11.3.1 Amerisource Bergen Corporation (World Courier)
  • 11.3.2 Deutsche Post DHL Group
  • 11.3.3 FedEx Corporation Services, Inc.
  • 11.3.4 United Parcel Service of America, Inc.
  • 11.3.5 Kuehne + Nagel International AG
  • 11.3.6 Cavalier Logistics, Inc.
  • 11.3.7 DB Schenker
  • 11.3.8 Life ConEx
  • 11.3.9 American Airlines Cargo
  • 11.3.10 Continental Group
  • 11.3.11 Marken